Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.

Filiaciones

Vincent, Laure:

CHU de Montpellier, Hôpital St Eloi, Montpellier, France.

Ceballos, Patrice:

CHU de Montpellier, Hôpital St Eloi, Montpellier, France

Finke, Juergen:

University of Freiburg, Freiburg, Germany

Passweg, Jakob:

University Hospital of Basel, Basel, Switzerland

Harel, Stephanie:

Hôpital St Louis, Paris, France

Rosinol, Laura:

Barcelona Hospital Clinic, Barcelona, Spain

Minnema, Monique:

University Medical Center Utrecht, Utrecht, Netherlands

Teipel, Raphael:

University Hospital Carl Gustav Carus, Dresden, Germany

Hänel M:

Klinikum Chemnitz, Chemnitz, Germany

Lenain, Pascal:

Centre Henri Becquerel, Rouen, France

Botella-Garcia, Carmen:

Hôpital Haut-Levèque, Pessac, France

Koenecke, Christian:

Hannover Medical School, Hannover, Germany

Ducastelle, Sophie:

CHU Lyon Sud, Pierre-Benite, France

Sanz, Jaime:

Hospital Universitari i Politècnic La Fe, Valencia, Spain

Schroyens, Wilfried:

Antwerp University Hospital (UZA), Antwerp-Edegem, Belgium

Zuckerman, Tsila:

Rambam Medical Center, Haifa, Israel

Monaco, Federico:

A.O. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

Koster, Linda:

EBMT Data Office, Leiden, UK

de Wreede, Liesbeth:

Leiden University Medical Center, Leiden, The Netherlands

Hayden, Patrick J.:

St. James Hospital, Trinity College Dublin, Dublin, Ireland

Schönland S:

University of Heidelberg, Heidelberg, Germany

Yakoub-Agha, Ibrahim:

CHU de Lille, Université de Lille, INSERM U1286, Infinite, Lille, France

Beksac, Meral:

Ankara University Faculty of Medicine, Ankara, Turkey